REAL and CALM: what have we learned?

Mov Disord. 2003 Jul;18(7):839-40. doi: 10.1002/mds.10448.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Benzothiazoles
  • Clinical Trials as Topic
  • Corpus Striatum / diagnostic imaging
  • Corpus Striatum / drug effects
  • Disease Progression
  • Dopamine / metabolism
  • Feasibility Studies
  • Humans
  • Indoles / therapeutic use*
  • Levodopa / therapeutic use*
  • Neurons / drug effects
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / drug therapy*
  • Pramipexole
  • Putamen / diagnostic imaging
  • Putamen / drug effects
  • Reference Values
  • Sensitivity and Specificity
  • Thiazoles / therapeutic use*
  • Tomography, Emission-Computed*
  • Tomography, Emission-Computed, Single-Photon*

Substances

  • Antiparkinson Agents
  • Benzothiazoles
  • Indoles
  • Neuroprotective Agents
  • Thiazoles
  • ropinirole
  • Levodopa
  • Pramipexole
  • Dopamine